HMGCR (m2): 293T Lysate: sc-120842

The HMGCR (m2): 293T Lysate is derived from the HEK293T cell line, a human embryonic kidney cell line favored for its high transfection efficiency and versatility in molecular biology research. This lysate contains 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR), the key enzyme in the mevalonate pathway responsible for converting HMG-CoA to mevalonate, a crucial step in cholesterol biosynthesis. HMGCR's activity is tightly regulated by feedback mechanisms involving sterol regulatory element-binding proteins (SREBPs) and the AMP-activated protein kinase (AMPK) pathway, influencing cellular cholesterol homeostasis and lipid metabolism. In research, the HMGCR (m2): 293T Lysate is utilized to study the biochemical and regulatory mechanisms of cholesterol synthesis. Researchers employ this lysate in in vitro assays to analyze HMGCR enzymatic activity, investigate its post-translational modifications, and understand the regulatory networks that control its expression and activity. This lysate is particularly valuable for exploring how alterations in HMGCR function impact lipid metabolism and cellular processes such as membrane synthesis and protein prenylation. Additionally, it aids in screening for modulators of HMGCR activity, providing insights into the broader implications of cholesterol regulation in cellular physiology and metabolic diseases. By leveraging this lysate, scientists gain a deeper understanding of the critical role of HMGCR in cellular lipid metabolism and homeostasis.